Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis
Top Cited Papers
- 30 January 2012
- journal article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 10 (7) , 776-783
- https://doi.org/10.1016/j.cgh.2012.01.012
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse modelJournal of Hepatology, 2010
- Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosisHepatology Research, 2009
- Vascular disorders of the liver # †Hepatology, 2009
- Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early AnticoagulationClinical Gastroenterology and Hepatology, 2008
- Extrahepatic Portal Vein ThrombosisSeminars in Liver Disease, 2008
- Hypercoagulation and thrombophilia in liver diseaseJournal of Thrombosis and Haemostasis, 2008
- Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests†‡Hepatology, 2005
- Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic ThrombophiliaEndoscopy, 2002
- Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant TherapyHepatology, 2000